MYOZYME® 50 mg
Powder for concentrate for solution for infusion
registration number
43/31/0745
What MYOZYME® 50 mg contains
Each vial contains 50 mg of alglucosidase alfa.
After reconstitution, the solution contains 5 mg/mL alglucosidase alfa (total extractable dose of 50 mg/10 mL).
other ingredients
Mannitol
Polysorbate 80 (Tween 80)
Sodium phosphate dibasic heptahydrate
Sodium phosphate monobasic monohydrate.
Therapeutic classification
A16AB0.